Original paper
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China
Volume: 20, Issue: 3, Pages: 313 - 320
Published: Apr 26, 2020
Abstract
Background Both amisulpride and olanzapine are leading treatments for schizophrenia in China. This study aimed to investigate the long-term cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China.Methods A decision-analytic Markov model was developed to simulate the lifetime clinical and economic outcomes of schizophrenia treatment from the healthcare payer perspective. The long-term costs and QALYs were...
Paper Details
Title
Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China
Published Date
Apr 26, 2020
Volume
20
Issue
3
Pages
313 - 320
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History